-
Extensive product ranges
-
Unrivalled customer care, knowledge and support
-
Log in for best experience
Decapeptyl 22.5mg Vial POM x1
In Stock
ℹ Please Note: We can only sell & ship Pharma items to registered medical professionals at registered medical premises.
If you are not Pharma approved, you should complete our
Online POM Form
and we will let you know when your account has been given Pharma Approval.
Powder and solvent for suspension for injection, sustained release formulation. Powder: White to off-white powder. Solvent: Clear solution.
Therapeutic indications
• Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration.
• Treatment of metastatic prostate cancer.
• As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
• As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
• As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.
• Treatment of central precocious puberty (CPP) in children 2 years and older with an onset of CPP before 8 years in girls and 10 years in boys).
Features
Nature and contents of container
• 6 mL septum vial with bromobutyl stopper and aluminium flip-off cap.
• Ampoule containing 2 mL of sterile solvent for suspension.
Special precautions for storage
• Do not store above 25°C. Keep the container in the outer carton. The reconstituted suspension for injection should be used immediately.
Shelf life
• The product should be used immediately after reconstitution.
Patient Information Leaflet
https://www.medicines.org.uk/emc/files/pil.5906.pdf
Presentation | Vial |
Presentation | Vial |
Pack size | 1 |
Presentation | Vial |